QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2015    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA 期刊论文 INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 卷号: 10, 页码: 1223-1233 作者:  Shao, Zhenyu;  Shao, Jingyu;  Tan, Bingxu;  Guan, Shanghui;  Liu, Zhulong 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17 co-delivery  nanostructured lipid carriers  transferrin decoration  active targeting systems  paclitaxel   MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 卷号: 47, 期号: 4, 页码: 1379-1392 作者:  Li, Haihui;  Zhang, Pei;  Sun, Xiaojin;  Sun, Yiming;  Shi, Chao 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/17 chemoresistance  epithelial-mesenchymal transition  microRNA-181a  PTEN  lung adenocarcinoma   Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review 期刊论文 DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 卷号: 9, 页码: 2171-2178 作者:  Yu, Qiaowen;  Guo, Qisen;  Chen, Liangan;  Liu, Shuwei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17 CDH1  methylation  lung cancer  meta-analysis  tumor suppressor gene  odds ratio   New development of inhibitors targeting the PI3K/AKT/mTOR pathway in personalized treatment of non-small-cell lung cancer 期刊论文 Anti-cancer drugs, 2015, 卷号: 26, 期号: 1, 页码: 1-14 作者:  Sun, Zhenguo;  Wang, Zhou;  Liu, Xiangyan;  Wang, Dong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/17 drug resistance  non-small-cell lung cancer  personalized therapy  PI3K/AKT/mTOR pathway